{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:53:48Z","timestamp":1767916428317,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cld.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T04:19:42Z","timestamp":1335327582000},"page":"285-299","source":"Crossref","is-referenced-by-count":36,"title":["Ascites"],"prefix":"10.1016","volume":"16","author":[{"given":"Fredric D.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2012.03.004_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: the natural history and prognostic factors","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib2","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.004_bib3","first-page":"153","article-title":"The mechanism of ascites formation in chronic liver disease","volume":"30","author":"Atkinson","year":"1961","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/gut.4.2.95","article-title":"The aetiology and management of ascites in patients with hepatic cirrhosis: a review","volume":"4","author":"Sherlock","year":"1963","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.03.004_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI106078","article-title":"Effective plasma volume in cirrhosis with ascites. Evidence that decreased volume does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis","volume":"48","author":"Lieberman","year":"1969","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2012.03.004_bib6","first-page":"R390","article-title":"Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity","volume":"238","author":"Kostreva","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2012.03.004_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0016-5085(89)90821-4","article-title":"Overflow theory of ascites formation","volume":"96","author":"Liebermann","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.1976.65","article-title":"Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis","volume":"9","author":"Schroeder","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/j.cld.2012.03.004_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2362.1981.tb01844.x","article-title":"Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the rennin-angiotensin-aldosterone system in cirrhosis with ascites","volume":"11","author":"Arroyo","year":"1981","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cld.2012.03.004_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities in sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1054\/mehy.1999.1034","article-title":"Hyperdynamic circulation in portal hypertension: a comparative model of arteriovenous fistula","volume":"55","author":"Wattanasirichaigoon","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cld.2012.03.004_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2008-1040318","article-title":"Portal hypertension and gastrointestinal bleeding","volume":"28","author":"Bosch","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.03.004_bib15","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure and experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/cs0890183","article-title":"Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or nonspecific effect?","volume":"89","author":"MacAllister","year":"1995","journal-title":"Clin Sci"},{"key":"10.1016\/j.cld.2012.03.004_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1478-3231.2008.01847.x","article-title":"Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistant index","volume":"28","author":"Cannaziga","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2012.03.004_bib19","first-page":"G339","article-title":"Intestinal capillary filtration in acute and chronic portal hypertension","volume":"254","author":"Korthuis","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2012.03.004_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/00365518009091957","article-title":"Filtration as the main transport mechanism of protein exchange between plasma and the peritoneal cavity and hepatic cirrhosis","volume":"40","author":"Henriksen","year":"1980","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cld.2012.03.004_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.22083","article-title":"Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis","volume":"47","author":"Frances","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis: a randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2012.03.004_bib24","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and have had a renal syndrome in cirrhosis: pathophysiological basis of therapy and current management","volume":"38","author":"Arroyo","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.004_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0016-5085(80)90197-3","article-title":"Hepatic hemodynamics in the renin-angiotensin-aldosterone system in cirrhotics","volume":"78","author":"Bosch","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJM198212163072504","article-title":"Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis","volume":"307","author":"Bichet","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib27","first-page":"530","article-title":"Arachidonic acid derivatives and renal function in liver cirrhosis","volume":"17","author":"Laffi","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.cld.2012.03.004_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"have had a renal syndrome","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.03.004_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib30","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0prospective, randomized, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS)","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","article-title":"Meta-analysis: terlipressin therapy for hepatorenal syndrome","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.03.004_bib32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"international liver transplantation expert panel. Report of the first international liver transplantation Society expert panel consensus conference on renal insufficiency in liver transplantation","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2012.03.004_bib34","first-page":"879","article-title":"Development of intractable ascites following upper abdominal surgery in patients with cirrhosis","volume":"80","author":"Brown","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.004_bib35","first-page":"377","article-title":"Chylous ascites complicating retroperitoneal lymphadenectomy for testis tumors: management with peritoneovenous shunting","volume":"120","author":"Miedema","year":"1978","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cld.2012.03.004_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jamcollsurg.2011.01.010","article-title":"Atraumatic chylous ascites: systematic review on symptoms and causes","volume":"212","author":"Steinemann","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cld.2012.03.004_bib37","first-page":"369","article-title":"Spontaneous chylous ascites of cirrhosis","volume":"6","author":"Rector","year":"1984","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.004_bib38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1681\/ASN.V551173","article-title":"Nephrogenic ascites: a poorly understood syndrome","volume":"5","author":"Hammond","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2012.03.004_bib39","first-page":"311","article-title":"Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management","volume":"3","author":"Guarner","year":"1995","journal-title":"Gastroenterologist"},{"key":"10.1016\/j.cld.2012.03.004_bib40","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/archinte.1986.00360230201029","article-title":"Paracentesis of ascitic fluid: a safe procedure","volume":"146","author":"Runyon","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2012.03.004_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510270139","article-title":"Management of adult patients with ascites caused by cirrhosis","volume":"27","author":"Runyon","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib43","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib44","series-title":"Clinics in liver disease: current and future treatment therapies for liver disease","first-page":"541","article-title":"Management of ascites","author":"Yu","year":"2001"},{"key":"10.1016\/j.cld.2012.03.004_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1517\/14656566.2011.549126","article-title":"Medical management of ascites","volume":"12","author":"Leung","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cld.2012.03.004_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.1840190113","article-title":"randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites","volume":"19","author":"Angeli","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib47","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJM197006182822502","article-title":"Compartmentalization of ascites and edema in patients with hepatic cirrhosis","volume":"282","author":"Shear","year":"1970","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib48","first-page":"212","article-title":"Urinary sodium\/potassium ratio on random sample as a useful tool to assess diuretic induced natriuresis on chronic liver disease-associated ascites","volume":"102","author":"Pinto-Marques","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.004_bib49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.004_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1148\/radiology.200.1.8657908","article-title":"Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment","volume":"200","author":"Crenshaw","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2012.03.004_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00003643-200310000-00003","article-title":"Albumin administration \u2013 what is the evidence of clinical benefit? a systematic review of randomized controlled trials","volume":"20","author":"Haynes","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.cld.2012.03.004_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.004_bib53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A\u00a0comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"Rossle","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib54","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American study for the treatment of refractory ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS vs. paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/gut.2004.038679","article-title":"Sepsis in cirrhosis: report on the seventh meeting of the International Ascites Club","volume":"54","author":"Wong","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.03.004_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.03.004_bib59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","article-title":"Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis","volume":"111","author":"Navasa","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.004_bib61","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis","volume":"56","author":"Sigal","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.03.004_bib62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","article-title":"current management of complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis","volume":"120","author":"Garcia-Tsao","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib64","first-page":"1171","article-title":"ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial","volume":"22","author":"Rolachon","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-122-8-199504150-00007","article-title":"Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial","volume":"122","author":"Singh","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2012.03.004_bib66","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.510250306","article-title":"Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin","volume":"25","author":"Novella","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.004_bib67","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.004_bib68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","article-title":"Norfloxacin primary prophylaxis of infections in patients with ascites: a double-blind randomized trial","volume":"29","author":"Grange","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.004_bib69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","article-title":"Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study","volume":"48","author":"Terg","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.004_bib70","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fernandez","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T03:17:03Z","timestamp":1642130223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1089326112000220"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.03.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}